Fitzgerald Joseph M.'s most recent trade in Boston Scientific Corp. was a trade of 34,898 Common Stock done . Disclosure was reported to the exchange on Feb. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 34,898 | 204,790 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2026 | 34,898 | 239,688 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 33,104 | 209,381 (0%) | 0% | 74.7 | 2,473,862 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 4,362 | 4,363 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 4,362 | 213,743 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,960 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 3,960 | 215,713 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,797 | 8,391 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 2,797 | 242,485 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,990 | 211,753 (0%) | 0% | 74.7 | 148,713 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.73 per share. | 13 Feb 2026 | 1,806 | 213,907 (0%) | 0% | 74.7 | 134,962 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 43,776 | 43,776 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 18,550 | 18,550 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 3,462 | 171,504 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2026 | 3,462 | 6,924 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.12 per share. | 12 Feb 2026 | 1,612 | 169,892 (0%) | 0% | 74.1 | 119,481 | Common Stock |
| Chain Bridge Bancorp Inc (Class A) | Joseph Michael Fitzgerald | Director | 17 Nov 2025 | 27,880 | 27,880 | - | 30.2 | 841,697 | Class A Common Stock | |
| Chain Bridge Bancorp Inc (Class A) | Joseph Michael Fitzgerald | Director | 17 Nov 2025 | 27,880 | 29,132 | - | 30.2 | 841,697 | Class A Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 9,610 | 168,042 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2025 | 690 | 177,652 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2025 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 03 Nov 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 99.14 per share. | 03 Nov 2025 | 29,472 | 178,342 (0%) | 0% | 99.1 | 2,921,895 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 99.76 per share. | 03 Nov 2025 | 16,928 | 207,814 (0%) | 0% | 99.8 | 1,688,749 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 100.75 per share. | 03 Nov 2025 | 3,600 | 224,742 (0%) | 0% | 100.7 | 362,693 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Oct 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 98.38 per share. | 01 Oct 2025 | 41,755 | 178,342 (0%) | 0% | 98.4 | 4,107,844 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 98.91 per share. | 01 Oct 2025 | 8,245 | 220,097 (0%) | 0% | 98.9 | 815,482 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 02 Sep 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 50,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 105.85 per share. | 02 Sep 2025 | 28,170 | 178,342 (0%) | 0% | 105.8 | 2,981,755 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 104.89 per share. | 02 Sep 2025 | 21,830 | 206,512 (0%) | 0% | 104.9 | 2,289,661 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 104.63 per share. | 01 Aug 2025 | 50,000 | 178,342 (0%) | 0% | 104.6 | 5,231,670 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Aug 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 50,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 01 Jul 2025 | 50,000 | 228,342 (0%) | 0% | 26.2 | 1,307,500 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 50,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 106.97 per share. | 01 Jul 2025 | 50,000 | 178,342 (0%) | 0% | 107.0 | 5,348,315 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 102.88 per share. | 04 Jun 2025 | 56,372 | 178,342 (0%) | 0% | 102.9 | 5,799,630 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.15 per share. | 04 Jun 2025 | 56,372 | 234,714 (0%) | 0% | 26.2 | 1,474,128 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 56,372 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 1,700 | 178,682 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 5,234 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2025 | 340 | 178,342 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Feb 2025 | 1,000 | 180,382 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,789 | 28,789 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 11,188 | 11,188 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 179,108 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,362 | 8,725 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 183,439 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 4,167 | 0 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 181,078 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 3,960 | 3,960 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 2,057 | 181,382 (0%) | 0% | 106.1 | 218,268 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,990 | 177,118 (0%) | 0% | 106.1 | 211,159 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.11 per share. | 13 Feb 2025 | 1,806 | 179,272 (0%) | 0% | 106.1 | 191,635 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 176,325 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2025 | 3,462 | 10,386 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.77 per share. | 12 Feb 2025 | 1,579 | 174,746 (0%) | 0% | 105.8 | 167,011 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 162,025 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 13,907 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Jan 2025 | 6,425 | 155,600 (0%) | 0% | 89.3 | 573,881 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2024 | 31,680 | 187,310 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.98 per share. | 03 Dec 2024 | 14,447 | 172,863 (0%) | 0% | 106.0 | 1,531,093 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Purchase of securities on an exchange or from another person at price $ 90.30 per share. | 03 Dec 2024 | 50 | 148,168 (0%) | 0% | 90.3 | 4,515 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 89.95 per share. | 03 Dec 2024 | 20 | 148,148 (0%) | 0% | 90.0 | 1,799 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 11,236 | 148,118 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Nov 2024 | 1,113 | 159,354 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 07 Oct 2024 | 132,527 | 160,467 (0%) | 0% | 85.0 | 11,264,888 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.26 per share. | 07 Oct 2024 | 59,021 | 235,376 (0%) | 0% | 17.3 | 1,018,702 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 59,021 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 57,618 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.98 per share. | 07 Oct 2024 | 57,618 | 292,994 (0%) | 0% | 25.0 | 1,439,298 | Common Stock |
| Chain Bridge Bancorp Inc (Class A) | Joseph Fitzgerald Michael | Director | Purchase of securities on an exchange or from another person at price $ 22.00 per share. | 03 Oct 2024 | 1,252 | 1,252 | - | 22 | 27,544 | Class A Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 28 Aug 2024 | 14,132 | 176,355 (0%) | 0% | 80 | 1,130,560 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2024 | 2,380 | 190,487 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | 20 Feb 2024 | 67,974 | 0 (0%) | 0% | 66.2 | 4,501,238 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 4,167 | 4,167 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 4,167 | 193,047 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,960 | 190,686 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,960 | 7,920 | - | - | Restricted Stock Units | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,706 | 0 | - | - | Deferred Stock Units | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 3,706 | 194,696 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Fitzgerald Joseph M. | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 2,057 | 190,990 (0%) | 0% | 65.8 | 135,392 | Common Stock |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,829 | 192,867 (0%) | 0% | 65.8 | 120,385 | Common Stock |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.82 per share. | 16 Feb 2024 | 1,806 | 188,880 (0%) | 0% | 65.8 | 118,871 | Common Stock |
| Boston Scientific | Joseph Fitzgerald M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 4,362 | 13,087 | - | - | Restricted Stock Units | |
| Boston Scientific | Joseph Fitzgerald M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 4,362 | 188,716 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Fitzgerald Joseph | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.95 per share. | 14 Feb 2024 | 1,990 | 186,726 (0%) | 0% | 66.0 | 131,241 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 33,332 | 206,804 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Feb 2024 | 16,450 | 190,354 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 12 Jan 2024 | 11,660 | 173,472 (0%) | 0% | 60 | 699,600 | Common Stock |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 29 Dec 2023 | 81,940 | 174,241 (0%) | 0% | 57.5 | 4,711,550 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.31 per share. | 29 Dec 2023 | 58,189 | 256,181 (0%) | 0% | 16.3 | 949,063 | Common Stock |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 58,189 | 0 | - | - | Stock Option (Right to Buy) | |
| Boston Scientific | Fitzgerald M. Joseph | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 21,799 | 0 | - | - | Performance Share Units | |
| Boston Scientific | Fitzgerald Joseph M. | EVP & Group Pres, Cardiology | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 21,799 | 196,040 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | M. Joseph Fitzgerald | EVP & Group Pres, Cardiology | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.81 per share. | 29 Dec 2023 | 10,908 | 185,132 (0%) | 0% | 57.8 | 630,591 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 20 Sep 2023 | 15,867 | 197,992 (0%) | 0% | 55 | 872,685 | Common Stock |
| Boston Scientific | Joseph M. Fitzgerald | EVP & Group Pres, Cardiology | Sale of securities on an exchange or to another person at price $ 53.60 per share. | 16 May 2023 | 63,339 | 213,859 (0%) | 0% | 53.6 | 3,394,856 | Common Stock |